ARCHIVES

AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

HCFA Draft Document Dampens Jubilation Over Clinton Plan To Pay Patient Care Costs.

June 16, 2000

The Cancer Letter Marks 25th Anniversary

December 18, 1998

Nimer to Lead Miami Sylvester Cancer Center

March 9, 2012

In Brief: Vicent Bono Retires As Investigational Drugs Branch Chief; Weiss to Leave For Walter Reed

January 9, 1981

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos

May 9, 1997